M C Liu1, G R Oxnard2, E A Klein3, C Swanton4, M Seiden5. 1. Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester. 2. Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston. 3. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA. 4. Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK. 5. US Oncology Research, US Oncology, The Woodlands, USA. Electronic address: michael.seiden@mckesson.com.
Authors: Christopher P Pacia; Jinyun Yuan; Yimei Yue; Lu Xu; Arash Nazeri; Rupen Desai; H Michael Gach; Xiaowei Wang; Michael R Talcott; Aadel A Chaudhuri; Gavin P Dunn; Eric C Leuthardt; Hong Chen Journal: Theranostics Date: 2022-01-01 Impact factor: 11.600